4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-090655
Options or other derivatives
- Chief Executive Officer acquired 1,968,016 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Noble James Chief Executive Officer | 2016-01-18 | Grant or award · Option to purchase Ordinary Shares | +1,968,016 | 1,968,016 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…